-
Notifications
You must be signed in to change notification settings - Fork 7
Revised May Lit Check #182
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Changes from 2 commits
File filter
Filter by extension
Conversations
Jump to
Diff view
Diff view
There are no files selected for viewing
| Original file line number | Diff line number | Diff line change |
|---|---|---|
|
|
@@ -44,7 +44,7 @@ | |
| "details": "Characterized in eight unrelated families which were used to establish benign (3-44) and pathogenic (118-694) ranges [@pmid:39068203].", | ||
| "omim": [], | ||
| "prevalence": null, | ||
| "prevalence_details": "Found in individuals of European ancestry [@pmid:38876750].", | ||
| "prevalence_details": "Found in individuals of European, Japanese, and Chinese ancestry [@pmid:38876750].", | ||
| "stripy": [], | ||
| "gnomad": [], | ||
| "genereviews": [], | ||
|
|
@@ -1511,7 +1511,7 @@ | |
| "typ_age_onset_max": 30.0, | ||
| "novel": "ref", | ||
| "mechanism": "GoF", | ||
| "mechanism_detail": "RNA gain-of-function: RNA gelation leading to misregulation of alternative splicing [@pmid:36169768]. Expanded-repeat RNA sequesters the muscleblind-like (MBNL) family of RNA-binding proteins as part of the disruption of pre-mRNA processing, contributing to cardiac phenotypes [@pmid:39932794].", | ||
| "mechanism_detail": "RNA gain-of-function: RNA gelation leading to misregulation of alternative splicing [@pmid:36169768]. Expanded-repeat RNA sequesters the muscleblind-like (MBNL) family of RNA-binding proteins as part of the disruption of pre-mRNA processing, contributing to cardiac phenotypes [@pmid:39932794]. Loss of MBNL proteins has been linked to mis-splicing of Autism spectrum-risk genes such as SCN2A, ANK2, and SHANK2, possibly leading to Autism-related traits [@pmid:40259070]", | ||
|
Member
There was a problem hiding this comment. Choose a reason for hiding this commentThe reason will be displayed to describe this comment to others. Learn more. Looks good! |
||
| "source": [], | ||
| "details": "Overview of disease locus through 2024, including largest pathogenic allele of 4,000, described in Rimoldi et al review [@pmid:39643839]. Intermediate alleles (35-49) associated with premutation [@genereviews:NBK1165]. 3%-8% of DM1 expansions contain interrupting variant repeats such as CCG and CGG, associated with later onset and milder phenotype; the variant repeat GCGGCA has also been reported [@pmid:32851192; @doi:10.1016/j.mcp.2024.102005]. In another study, interruptions of the CTG repeat with CCG, GGC, CTC or CAG motifs are estimated to occur in 3-11% of DM1 patients [@pmid:35741732]. Expansions within gene ZNF850 may function as DM1 modifiers [@doi:10.1093/hmg/ddae186].", | ||
| "omim": ["160900"], | ||
|
|
@@ -1529,7 +1529,7 @@ | |
| "webstr_hg38": ["5650727"], | ||
| "webstr_hg19": ["Expansion_DM1/DMPK"], | ||
| "tr_atlas": ["TR156684"], | ||
| "disease_description": "Steinert disease, also known as myotonic dystrophy type 1, is a muscle disease characterized by myotonia and by multiorgan damage that combines various degrees of muscle weakness, arrhythmia and/or cardiac conduction disorders, cataract, endocrine damage, sleep disorders and baldness [@mondo:0008056].", | ||
| "disease_description": "Steinert disease, also known as myotonic dystrophy type 1, is a muscle disease characterized by myotonia and by multiorgan damage that combines various degrees of muscle weakness, arrhythmia and/or cardiac conduction disorders, cataract, endocrine damage, sleep disorders and baldness [@mondo:0008056]. It has also been linked to Autism Spectrum Disorder and related traits [@pmid:29361396; @pmid:8810716; @pmid:27695335; @pmid:29871899; @pmid:37209486], the presence of which may be associated with age of onset of DM1 [@pmid:40259070].", | ||
|
||
| "locus_tags": ["somatic_instability", "anticipation", "maternal_expansion", "length_affects_onset", "length_affects_phenotype", "length_affects_severity", "motif_affects_instability", "motif_affects_onset", "motif_affects_phenotype", "motif_affects_severity"], | ||
| "disease_tags": ["myotonic_dystrophy"], | ||
| "references": ["genereviews:NBK1165", "pmid:38454488", "pmid:36169768", "pmid:39932794", "pmid:39643839", "pmid:32851192", "doi:10.1016/j.mcp.2024.102005", "pmid:35741732", "doi:10.1093/hmg/ddae186", "pmid:29100084", "pmid:31159885", "pmid:35483324", "pmid:1310900", "mondo:0008056"], | ||
|
|
@@ -1644,7 +1644,7 @@ | |
| "details": "Higher repeat size is associated with earlier age of onset [@pmid:39263992]. The 250-300 repeats range is linked to incomplete penetrance and >300 repeats with complete penetrance in some studies and resources [@genereviews:NBK599589; @pmid:37399286; @pmid:39227614]. However, our thresholds are taken from suggestions made by Mohren et al upon evaluation of 169 cases and 802 controls; the authors propose lower thresholds based on pathogenic cases of shorter pure repeats [@pmid:39227614]. Additionally, this study suggests that benign motifs may disrupt the formation of secondary structures in DNA/RNA, leading to reduced pathogenicity. The affect of interruptions on penetrance and onset has been shown in patients, with uninterrupted expansions apparently necessary for disease [@pmid:40007153]. Variation in flanking regions appear to correlate with repeat size [@pmid:39227614; @pmid:38937606]. Intermediate alleles make pose as susceptibility factors or be associated with a phenotypic spectrum (multiple system atrophy) [@pmid:39227614; @pmid:39604554].", | ||
| "omim": ["620174"], | ||
| "prevalence": null, | ||
| "prevalence_details": "Intermediate expansions 1-2% of population, but non-GAA-pure without relation to ataxia [@genereviews:NBK599589]. Found in multiple ethnicities [@pmid:38876750]; diagnosed patients in America, Brazil, Japan, Germany, Spain, Canada, France, Austria and Australia [@genereviews:NBK599589].", | ||
| "prevalence_details": "Intermediate expansions 1-2% of population, but non-GAA-pure without relation to ataxia [@genereviews:NBK599589]. Found in multiple ethnicities [@pmid:38876750]; diagnosed patients in America, Brazil, Japan, Germany, Spain, Canada, France, Austria, Australia, and Italy [@genereviews:NBK599589; @pmid:38886208].", | ||
|
||
| "stripy": ["FGF14"], | ||
| "gnomad": [], | ||
| "genereviews": ["NBK599589"], | ||
|
|
@@ -2281,7 +2281,7 @@ | |
| "mechanism": "GoF/LoF", | ||
| "mechanism_detail": "While the primary pathogenic mechanism is gain of function of the protein product, pathogenesis is complex and multifactorial [@pmid:27940602].", | ||
| "source": [], | ||
| "details": "27-35 motifs are unstable/premutations, while 36-39 motifs are associated with reduced penetrance and mild phenotypes [@pmid:39572770]. >60 motifs assocated with onset age <20 years [@genereviews:NBK1305]. Only CAG expansions are considered pathogenic, but interruptions impact pathogenicity (e.g. CAA) [@pmid:35245110]. Only fathers with premutations are considered at risk of transmitting pathogenic alleles [@pmid:19507258]. CAG repeats in the non-HD range (>= 21 repeats) may modulate psychiatric disease risk in an age-dependent manner [@pmid:39572770]", | ||
| "details": "27-35 motifs are unstable/premutations, while 36-39 motifs are associated with reduced penetrance and mild phenotypes [@pmid:39572770]. >60 motifs associated with onset age <20 years [@genereviews:NBK1305]. Only CAG expansions are considered pathogenic, but interruptions impact pathogenicity (e.g. CAA) [@pmid:35245110]. Only fathers with premutations are considered at risk of transmitting pathogenic alleles [@pmid:19507258]. CAG repeats in the non-HD range (>= 21 repeats) may modulate psychiatric disease risk in an age-dependent manner [@pmid:39572770]", | ||
| "omim": ["143100"], | ||
| "prevalence": "1/10000", | ||
| "prevalence_details": "6.5-15/100,000 [@pmid:29100084]. 9.71-17:100,000 (European) vs. 0.1-2/100,000 (African), as many as 1 in 400 have reduced penetrance (0.2-2% for 36-38 CAG) HTT alleles [@genereviews:NBK1305]. Found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1305].", | ||
|
|
@@ -2348,7 +2348,7 @@ | |
| "details": "Intermediate alleles (29-39) may either be premutations or associated with reduced penetrance; the longest pathogenic expansion (40+ motifs) to date is 60 repeats [@genereviews:NBK1529]", | ||
| "omim": ["606438"], | ||
| "prevalence": null, | ||
| "prevalence_details": "<1/1,000,000 [@orphanet:98934]. Largely in individuals of African ancestry [@genereviews:NBK1529].", | ||
| "prevalence_details": "<1/1,000,000 [@orphanet:98934]. Largely in individuals of African ancestry [@genereviews:NBK1529]. JPH3 is a possible founder mutation in individuals of African ancestry [@pmid:40187026].", | ||
|
Member
There was a problem hiding this comment. Choose a reason for hiding this commentThe reason will be displayed to describe this comment to others. Learn more. Looks good |
||
| "stripy": ["JPH3"], | ||
| "gnomad": ["JPH3"], | ||
| "genereviews": ["NBK1529"], | ||
|
|
@@ -4384,8 +4384,8 @@ | |
| "pathogenic_max": 74.0, | ||
| "ref_copies": 21.3, | ||
| "motif_len": 3, | ||
| "age_onset": "Typical: 37- 56; Range: 15 - 60 [@pmid:38035881; @pmid:38973251].", | ||
| "age_onset_min": 15, | ||
| "age_onset": "Typical: 37- 56; Range: 12 - 60 [@pmid:39666847; @pmid:38973251].", | ||
| "age_onset_min": 12, | ||
| "age_onset_max": 60, | ||
|
||
| "typ_age_onset_min": 37.0, | ||
| "typ_age_onset_max": 56.0, | ||
|
|
||
There was a problem hiding this comment.
Choose a reason for hiding this comment
The reason will be displayed to describe this comment to others. Learn more.
Which paper is this from?